HIV-reservoir size is not affected either by HCV coinfection or by direct acting antivirals (DAAs) therapy

[1]  E. Ruiz-Mateos,et al.  Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus , 2020, Antimicrobial Agents and Chemotherapy.

[2]  S. Lewin,et al.  Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy , 2020, Open forum infectious diseases.

[3]  J. Benito,et al.  HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study , 2019, Scientific Reports.

[4]  B. Domínguez-Molina,et al.  Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients , 2018, The Journal of infectious diseases.

[5]  Xu G. Yu,et al.  Pegylated Interferon-&agr;–Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy–Treated HIV-1/Hepatitis C Virus–Coinfected Patients , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  G. Palù,et al.  Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment , 2018, Medical Microbiology and Immunology.

[7]  G. Palù,et al.  Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment , 2018, Medical Microbiology and Immunology.

[8]  M. Capobianchi,et al.  Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals , 2017, PloS one.

[9]  J. Benito,et al.  HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells , 2017, PloS one.

[10]  Wim Trypsteen,et al.  Diagnostic utility of droplet digital PCR for HIV reservoir quantification , 2016, Journal of virus eradication.

[11]  M. Lichterfeld,et al.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth , 2016, PLoS pathogens.

[12]  Wei-jun Zhu,et al.  Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients. , 2015, Antiviral research.

[13]  Xu G. Yu,et al.  Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patients. , 2014, The Journal of infectious diseases.

[14]  A. Landay,et al.  Characterization of CD4+ T-Cell Immune Activation and Interleukin 10 Levels Among HIV, Hepatitis C Virus, and HIV/HCV-Coinfected Patients , 2013, Journal of acquired immune deficiency syndromes.

[15]  J. Blackard,et al.  Effects of HCV on Basal and Tat-Induced HIV LTR Activation , 2013, PloS one.

[16]  L. Montaner,et al.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials , 2012, AIDS.

[17]  J. Fellay,et al.  Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo , 2012, Proceedings of the National Academy of Sciences.

[18]  Pedagógia,et al.  Cross Sectional Study , 2019 .